CYP1B1 and neoplasm: Although one reason for this disparity could be the increased sensitivity of transcript detection compared to protein, the lower expression of CYP1B1 in cancerous tissue relative to adjacent could also be attributed to the possible downregulation of the gene by the AhR repressor in the tumour or by methylation of the promoter region, resulting in epigenetic silencing [52].